Medical College Department Finalizes New Name
Published January 2008
The genome science department—a UC College of Medicine unit located at UC’s Genome Research Institute (GRI)—has changed its name to better reflect the department’s research focus.
The new name, department of molecular oncogenesis, was approved by the UC Board of Trustees in November and became effective Dec. 1.
Jorge Moscat, PhD, professor and interim chair of molecular oncogenesis, says the department will continue to focus on the roles of specific disease pathways, oncogenes (genes that can transform normal cells into cancerous ones), growth factors, the cellular “microenvironment” and tumor development and progression.
“This name change makes clear the connection between our department and the College of Medicine’s efforts to expand its cancer research initiatives,” says Moscat.
“But although cancer is a unifying theme for molecular oncogenesis faculty, cancer-causing pathways and genes are also involved in many other diseases in-cluding asthma and diabetes,” he says.
“Researchers in our department will continue to study these diseases as well.”
The department of molecular oncogenesis is part of a joint cancer program involving the UC College of Medicine, Cincinnati Children’s Hospital Medical Center and University Hospital.
The GRI, founded in 2001, is home to internationally recruited scientists researching the genetic basis of some of the world’s most serious and prevalent diseases, including obesity, heart disease and cancer.